In the third quarter, sales of the cancer drug Verzenio soared by 32% year over year to $1.4 billion. Newer products like Alzheimer's medicine Kisunla will eventually help drive growth. Further, Eli ...

Researchers at the University of Copenhagen have identified a new drug target for weight loss that curbs appetite, boosts ...

State Medicaid programs for low-income families are the single biggest source of coverage, giving 31.6 million people access to Novo Nordisk (NYSE: NVO )'s Wegovy or Eli Lilly (NYSE: LLY )'s Zepbound, ...

U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...

Eyenovia has seen its stock price plummet by more than two-thirds after a Phase III study of its drug-device combination for ...